These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2603892)

  • 21. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
    Periclou A; Ventura D; Rao N; Abramowitz W
    Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers.
    Lü Y; Kang ZS; Zhu Y; Zhang M; Liu Y; Zhang M; Li TY; Xiao YH
    Chin Med J (Engl); 2011 Jan; 124(2):242-5. PubMed ID: 21362374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin in human serum, urine, and tear film after topical application.
    Borrmann L; Tang-Liu DD; Kann J; Nista J; Lin ET; Frank J
    Cornea; 1992 May; 11(3):226-30. PubMed ID: 1587130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of the antirheumatic lonazolac-Ca in humans].
    Huber R; Zech K; Dittmann EC; Lühmann R; Petitet A
    Arzneimittelforschung; 1990 Aug; 40(8):918-25. PubMed ID: 2242085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
    Rebuck JA; Fish DN; Abraham E
    Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.
    Yuen GJ; Drusano GL; Brooks J; Flor S
    Pharmacotherapy; 1992; 12(2):88-92. PubMed ID: 1570232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modification of ofloxacin pharmacokinetics induced by prolonged mechanical ventilation].
    Martin C; Lambert D; Saux P; Meugnier H; Bruguerolle B; Freney J; Fleurette J; Gouin F
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):508-12. PubMed ID: 2385447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of antofloxacin hydrochloride in healthy male subjects after multiple intravenous dose administration.
    Wang J; Xiao Y; Lu Y; Kang Z; Zhang M; Liu Y; Liang J; Zhang M; Li T
    Xenobiotica; 2011 Jul; 41(7):561-6. PubMed ID: 21446836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects.
    Molinaro M; Villani P; Regazzi MB; Rondanelli R; Doveri G
    Eur J Clin Pharmacol; 1992; 43(1):105-7. PubMed ID: 1505603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.
    White LO; MacGowan AP; Mackay IG; Reeves DS
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():65-72. PubMed ID: 3182464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.